AstraZeneca (AZD1222) COVID-19 vaccine-associated adverse drug event: A case report

J Med Virol. 2021 Oct;93(10):5718-5720. doi: 10.1002/jmv.27175. Epub 2021 Jul 8.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Autoimmunity / drug effects
  • COVID-19 / prevention & control
  • COVID-19 Vaccines / adverse effects*
  • COVID-19 Vaccines / immunology
  • ChAdOx1 nCoV-19
  • Drug-Related Side Effects and Adverse Reactions / diagnosis
  • Drug-Related Side Effects and Adverse Reactions / etiology*
  • Drug-Related Side Effects and Adverse Reactions / therapy
  • Female
  • Humans
  • Polymyositis / diagnosis
  • Polymyositis / etiology
  • Polymyositis / therapy
  • SARS-CoV-2 / immunology
  • Sweet Syndrome / diagnosis
  • Sweet Syndrome / etiology
  • Sweet Syndrome / therapy

Substances

  • COVID-19 Vaccines
  • ChAdOx1 nCoV-19